[go: up one dir, main page]

CN114573446B - Method for preparing protocatechuic acid from phellinus linteus medicinal material - Google Patents

Method for preparing protocatechuic acid from phellinus linteus medicinal material Download PDF

Info

Publication number
CN114573446B
CN114573446B CN202011403414.0A CN202011403414A CN114573446B CN 114573446 B CN114573446 B CN 114573446B CN 202011403414 A CN202011403414 A CN 202011403414A CN 114573446 B CN114573446 B CN 114573446B
Authority
CN
China
Prior art keywords
protocatechuic acid
acid
filler
water
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011403414.0A
Other languages
Chinese (zh)
Other versions
CN114573446A (en
Inventor
丰加涛
梁鑫淼
钟正升
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN202011403414.0A priority Critical patent/CN114573446B/en
Publication of CN114573446A publication Critical patent/CN114573446A/en
Application granted granted Critical
Publication of CN114573446B publication Critical patent/CN114573446B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/47Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/10Process efficiency

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a method for preparing protocatechuic acid from phellinus linteus medicinal material, which comprises the steps of extracting the phellinus linteus medicinal material with pure water, adopting a two-dimensional orthogonal liquid chromatography technology, enriching pure water resistant C8YE silica gel filler as a separation material to obtain crude protocatechuic acid in one dimension, and preparing and purifying the crude protocatechuic acid in two dimensions by using polar copolymerization C18HC bonded silica gel filler to obtain a protocatechuic acid product with the purity of more than 95 percent. The preparation process of the invention has stable process, high yield, high automation degree and easy operation, and can meet the requirement of large-scale production.

Description

一种从桑黄药材中制备原儿茶酸的方法A method for preparing protocatechuic acid from phellinus medicinal material

技术领域technical field

本方法涉及分离纯化技术领域,具体是一种从桑黄药材中制备原儿茶酸的方法。更进一步的,本发明是利用二维液相色谱技术从桑黄药材中制备高纯度原儿茶酸的方法,纯度可以达到95%以上。The method relates to the technical field of separation and purification, in particular to a method for preparing protocatechuic acid from Phellinus phellifolia. Further, the present invention is a method for preparing high-purity protocatechuic acid from the Phellinus phylloxera medicinal material by using two-dimensional liquid chromatography technology, and the purity can reach more than 95%.

背景技术Background technique

桑黄是一种珍贵的多年生大型药用真菌,素有“森林黄金”之美称之美称,在《本草纲目》中有记载。属于担子菌门层菌纲非褶菌目多孔菌科针层孔菌属,在我国分布有四十个种。主要寄生在桑、柳、桦杨栎等树干上,其中以野生的桑树桑黄最为珍贵。Phellinus is a precious perennial large medicinal fungus, known as "forest gold", which is recorded in "Compendium of Materia Medica". Belonging to the Basidiomycota Phyllomycetes, Polyporaceae Acupunculus genus, there are 40 species distributed in my country. It mainly parasitizes on the trunks of mulberry, willow, birch, poplar and oak, among which the wild mulberry Phellinus is the most precious.

桑黄作为我国传统真菌类中药,是目前国际公认的生物治癌领域中有效率排在第一位的药用菌。其包含多种结构类型的化学成分,包括多糖、黄酮、三萜类、芳香酸、氨基酸等;现代药理学实验也表明,桑黄具抗癌、免疫调节、抗肥胖、抗氧化和抗炎等多种药理学活性。Phellinus Phellinus, as a traditional fungal traditional Chinese medicine in my country, is currently internationally recognized as the most effective medicinal fungus in the field of biological cancer treatment. It contains chemical components of various structural types, including polysaccharides, flavonoids, triterpenoids, aromatic acids, amino acids, etc.; modern pharmacological experiments also show that Phellinus has anti-cancer, immune regulation, anti-obesity, anti-oxidation, and anti-inflammatory properties. Various pharmacological activities.

近年来,在天然化合物中寻找具有神经营养样作用且可增强神经营养因子作用的双靶标药物成为研究的热点。据研究表明原儿茶酸具有抗癌、抗氧化、抗炎症、降血糖等多种功效,是一种健康安全的有益小分子物质。In recent years, searching for dual-target drugs with neurotrophic-like effects and enhancing the effects of neurotrophic factors in natural compounds has become a research hotspot. According to research, protocatechuic acid has various functions such as anti-cancer, anti-oxidation, anti-inflammation, and hypoglycemia, and is a healthy and safe beneficial small molecule substance.

原儿茶酸(3,4-二羟基苯甲酸),性状为白色粉末,结构式如下:Protocatechuic acid (3,4-dihydroxybenzoic acid), the property is a white powder, the structural formula is as follows:

Figure BDA0002813149430000021
Figure BDA0002813149430000021

原儿茶酸分子式中具有多个-OH,与硅胶表面的硅醇基有一定的结合作用,这是导致该物质制备过程中拖尾严重、分离困难的主要原因,为了解决该问题,该专利所使用的一维和二维分离填料,分别采用多点温和键合、封尾技术和极性共聚等技术对填料表面进行处理,大大改善制备过程中的拖尾问题;There are multiple -OH in the molecular formula of protocatechuic acid, which has a certain binding effect with the silanol groups on the surface of silica gel, which is the main reason for the serious tailing and difficult separation during the preparation of the substance. In order to solve this problem, the patent The one-dimensional and two-dimensional separation fillers used are respectively treated with multi-point mild bonding, end-sealing technology and polar copolymerization technology to treat the surface of the filler, which greatly improves the tailing problem in the preparation process;

原儿茶酸具有抗血小板凝集、降低心肌耗氧量、抑菌、镇痛等多方面药理活性,是一种重要的天然活性物质。近年来的研究发现了其具有抗氧化、抗癌及介导肿瘤细胞凋亡等许多新的药理作用;对缺血缺氧神经元具有一定的神经细胞保护作用;能显著的缓解白细胞介素1β对软骨细胞的炎症反应;能维持受损的软骨细胞的表型和促增殖作用;维持软骨细胞表型和促进细胞增殖等等。Protocatechuic acid has various pharmacological activities such as anti-platelet aggregation, reducing myocardial oxygen consumption, antibacterial, analgesic, etc., and is an important natural active substance. In recent years, studies have found that it has many new pharmacological effects such as anti-oxidation, anti-cancer and mediating tumor cell apoptosis; it has a certain protective effect on nerve cells in ischemic and hypoxic neurons; it can significantly relieve interleukin 1β Inflammatory response to chondrocytes; can maintain the phenotype of damaged chondrocytes and promote proliferation; maintain chondrocyte phenotype and promote cell proliferation, etc.

原儿茶酸具有较强的抗氧化能力,对金黄色葡萄球菌、链球菌等具有明显抑制作用,并有收敛和促进伤面愈合的作用,可用于治疗炎症、发热和癌症等。Protocatechuic acid has strong antioxidant capacity, has obvious inhibitory effect on Staphylococcus aureus, streptococcus, etc., and has the effect of astringent and promoting wound healing. It can be used to treat inflammation, fever and cancer.

从桑黄药材中提取制备原儿茶酸罕有报道,谱效关系不明确,因此制备该化合物对桑黄物质基础研究和药理活性研究具有重要意义;There are few reports on the preparation of protocatechuic acid from Phellinus chinensis, and the spectrum-effect relationship is not clear. Therefore, the preparation of this compound is of great significance for the basic research and pharmacological activity of Phellinus chinensis;

鉴于以上技术背景及发展前景,提出本发明。In view of the above technical background and development prospects, the present invention is proposed.

发明内容Contents of the invention

本发明提供一种以桑黄药材为原料,采用二维液相色谱制备原儿茶酸的方法,操作步骤如下:The invention provides a method for preparing protocatechuic acid by using two-dimensional liquid chromatography with Phellinus phellifolia as a raw material, and the operation steps are as follows:

1.作为优选,利用桑黄药材采用纯水提取,料液比1:15~30,浸泡10~24小时,加热煮沸水提1~2小时,提取2~3次,合并得到水提液;1. As a preference, use the Phellinus medicinal material to extract with pure water, the ratio of solid to liquid is 1:15-30, soak for 10-24 hours, heat and boil water for 1-2 hours, extract 2-3 times, and combine to obtain the water extract;

2.作为优选,采用膜过滤技术对水提液进行中空纤维膜过滤,中空纤维膜滤芯精度10000~800000分子量,得到中空纤维膜透过液;2. As a preference, adopt membrane filtration technology to carry out hollow fiber membrane filtration to the water extract, and the precision of the hollow fiber membrane filter element is 10,000-800,000 molecular weight to obtain the hollow fiber membrane permeate;

3.作为优选,利用耐纯水C8YE硅胶填料,对原儿茶酸具有很好的富集作用,可以将中空纤维膜水相透过液进行大体积直接上样富集,填料为粒径30~60μm,孔径为

Figure BDA0002813149430000031
富集获得原儿茶酸粗品。3. As a preference, pure water-resistant C8YE silica gel filler is used, which has a good enrichment effect on protocatechuic acid. It can directly enrich the water phase permeate of the hollow fiber membrane in a large volume. The filler has a particle size of 30 ~60μm, the pore size is
Figure BDA0002813149430000031
Enrichment to obtain crude protocatechuic acid.

4.为了实现一维制备富集原儿茶酸粗品的目的,本发明采用了以下的技术方案:4. In order to realize the purpose of one-dimensionally preparing and enriching the crude product of protocatechuic acid, the present invention adopts the following technical solutions:

一维液相色谱制备采用的洗脱条件为丙酮、乙腈、异丙醇(有机相)与酸水(水相)混合,水相为乙酸或磷酸中的一种或二种,比例为0.1~0.5%(v/v),按照有机相5~25%等度,5~25%线性梯度或台阶梯度,流速为0.1~0.2倍填料体积/min,温度25~45℃,载样量0.5~3.0%(样品溶液固体质量与填料质量之比),检测器为DAD紫外检测器,洗脱时间为20~60min,按照检测器色谱峰曲线收集馏分,对所有馏分进行液相分析,确认原儿茶酸馏分,合并后浓缩至20~80mg/mL为一维制备原儿茶酸粗品;The elution condition used in the preparation of one-dimensional liquid chromatography is a mixture of acetone, acetonitrile, isopropanol (organic phase) and acidic water (water phase), and the water phase is one or two of acetic acid or phosphoric acid, the ratio is 0.1~ 0.5% (v/v), according to organic phase 5-25% isocratic, 5-25% linear gradient or step gradient, flow rate 0.1-0.2 times packing volume/min, temperature 25-45°C, sample loading 0.5- 3.0% (the ratio of the solid mass of the sample solution to the packing mass), the detector is a DAD ultraviolet detector, the elution time is 20-60min, the fractions are collected according to the chromatographic peak curve of the detector, and all fractions are analyzed by liquid phase to confirm the original Theophyllic acid fractions, combined and concentrated to 20-80mg/mL, are one-dimensional preparation of crude protocatechuic acid;

5.作为优选,二维制备采用极性共聚C18HC键合硅胶填料,填料粒径为10~40μm,孔径为

Figure BDA0002813149430000041
制备获得纯度>95%原儿茶酸;5. As a preference, polar copolymer C18HC bonded silica gel filler is used for two-dimensional preparation, the particle size of the filler is 10-40 μm, and the pore size is
Figure BDA0002813149430000041
Preparation of protocatechuic acid with a purity >95%;

6.为了实现二维制备原儿茶酸的目的,本发明采用了以下的技术方案:6. In order to realize the purpose of two-dimensional preparation of protocatechuic acid, the present invention adopts the following technical solutions:

二维液相色谱制备采用洗脱条件为丙酮、乙腈、异丙醇(有机相)与甲酸水(水相)混合,按照有机相5~25%等度,5~25%梯度或台阶等度,水相为甲酸比例为0.1~1.2%(v/v),流速为0.2~0.3倍填料体积/min,温度25~45℃,载样量0.2~2.0%(样品质量与填料质量之比),检测器为DAD紫外检测器,洗脱时间为30~80min,按照检测器色谱峰曲线对原儿茶酸的组分进行收集,所得馏分真空干燥,即可得到纯度>95%的原儿茶酸。The two-dimensional liquid chromatography preparation adopts the elution condition of mixing acetone, acetonitrile, isopropanol (organic phase) and formic acid water (water phase), according to the organic phase 5-25% isocratic, 5-25% gradient or step isocratic , the water phase is formic acid, the proportion is 0.1-1.2% (v/v), the flow rate is 0.2-0.3 times the filler volume/min, the temperature is 25-45°C, and the sample loading is 0.2-2.0% (ratio of sample mass to filler mass) , the detector is a DAD ultraviolet detector, and the elution time is 30 to 80 minutes. The components of protocatechuic acid are collected according to the chromatographic peak curve of the detector, and the obtained fraction is vacuum-dried to obtain protocatechu with a purity of >95%. acid.

本发明具有如下优点:The present invention has the following advantages:

本发明与现有技术相比具有以下特点:Compared with the prior art, the present invention has the following characteristics:

1.桑黄化合物的一维分离填料采用耐纯水的合成工艺,可以对纯水相样品进行大体积上样,可以避免普通C18键合填料的键合相卷曲,失去保留的问题,二维分离填料采用极性共聚C18HC键合硅胶填料,对一维桑黄化合物原儿茶酸进行正交性分离,与一维分离填料具有互补性;1. The one-dimensional separation packing of Phellinus compound adopts a pure water-resistant synthesis process, which can load a large volume of pure water phase samples, and can avoid the problem of curling and loss of retention of the bonded phase of ordinary C18 bonded packings. Two-dimensional The separation packing adopts the polar copolymer C18HC bonded silica gel packing, which is used for the orthogonal separation of the one-dimensional Phellinus compound protocatechuic acid, which is complementary to the one-dimensional separation packing;

2.原儿茶酸纯度高:由于本发明所用的技术方法,直接针对药材中所含的原儿茶酸进行制备,无需经过加热、酸碱的变化,原儿茶酸以在药材中本身存在的状态被制备出来,没有水解产物掺杂,因此得到的原儿茶酸纯度高,达到95%以上。2. High purity of protocatechuic acid: due to the technical method used in the present invention, the protocatechuic acid contained in the medicinal materials is directly prepared without heating and acid-base changes, and the protocatechuic acid itself exists in the medicinal materials The state is prepared without hydrolyzate doping, so the obtained protocatechuic acid has a high purity of more than 95%.

3.本发明所涉及的制备原儿茶酸的方法,仪器自动化程度高,操作简便,收率高,可以满足大规模生产的需求。3. The method for preparing protocatechuic acid involved in the present invention has a high degree of automation of the instrument, is easy to operate, and has a high yield, which can meet the needs of large-scale production.

附图说明Description of drawings

图1是实施例1的原儿茶酸一维制备谱图;Fig. 1 is the one-dimensional preparation spectrogram of protocatechuic acid of embodiment 1;

图2是实施例1的原儿茶酸二维制备谱图;Fig. 2 is the two-dimensional preparation spectrogram of protocatechuic acid of embodiment 1;

图3是实施例1的原儿茶酸液相分析谱图。Fig. 3 is the protocatechuic acid liquid phase analysis spectrogram of embodiment 1.

具体实施方式Detailed ways

现结合实例,对本发明做进一步说明。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和变型,这些改进和变型也应视为本发明的保护范围。实例仅限于说明本发明,本发明不仅限于此。Now in conjunction with examples, the present invention will be further described. It should be pointed out that for those skilled in the art, some improvements and modifications can be made without departing from the technical principle of the present invention, and these improvements and modifications should also be regarded as the protection scope of the present invention. The examples are only for illustrating the present invention, and the present invention is not limited thereto.

实施例1Example 1

称取桑黄药材100g,加入3L水溶液,浸泡24小时后加热煮沸水提8小时,收集水提液,固体物料再次按加入3L水溶液重复加水煮沸提收集水提液,重复提取1次,合并得到水提液,得到桑黄药材水提溶液,浓度为1.8mg/mL,中空纤维膜过滤(膜芯精度100000分子量)。Weigh 100g of Phellinus medicinal material, add 3L of aqueous solution, soak for 24 hours, heat and boil water for 8 hours, collect the water extract, add 3L of water solution and repeatedly add water and boil to collect the water extract, repeat the extraction once, and combine to obtain The aqueous extract was obtained to obtain an aqueous extract of the Phellinus medicinal material with a concentration of 1.8 mg/mL, which was filtered through a hollow fiber membrane (the precision of the membrane core was 100,000 molecular weight).

一维制备条件,色谱条件采用C8YE填料(制备柱规格:100×250mm,粒径30μm,孔径

Figure BDA0002813149430000051
质量1200g,华谱新创科技有限公司),流动相采用(A)乙腈(有机相)-(B)0.1%乙酸水(水相,v/v),梯度洗脱方式:纯水洗脱10min,乙腈(流动相A)体积浓度由10%经60min提高到20%乙腈(其余为流动相B)梯度洗脱60min,采用DAD紫外检测器选择254nm吸收波长,制备温度25℃,上样体积为3.3L/针,载样量0.5%(样品溶液固体质量与填料质量之比),流动相流速为300mL/min,按照检测器色谱峰曲线收集馏分,对所有馏分进行液相分析,确认原儿茶酸馏分,合并后浓缩至30mg/mL,得到一维制备原儿茶酸粗品,纯度36.51%,收率86.9%。One-dimensional preparation conditions, chromatographic conditions using C8YE filler (preparation column size: 100 × 250mm, particle size 30μm, pore size
Figure BDA0002813149430000051
Mass 1200g, Huapu Xinchuang Technology Co., Ltd.), the mobile phase is (A) acetonitrile (organic phase) - (B) 0.1% acetic acid water (water phase, v/v), gradient elution method: pure water elution 10min , acetonitrile (mobile phase A) volume concentration is increased to 20% acetonitrile (all the other are mobile phase B) gradient elution 60min by 10% through 60min, adopts DAD ultraviolet detector to select 254nm absorption wavelength, preparation temperature 25 ℃, loading sample volume is 3.3L/needle, sample load 0.5% (ratio of solid mass of sample solution to packing mass), flow rate of mobile phase is 300mL/min, collect fractions according to detector chromatographic peak curve, perform liquid phase analysis on all fractions, confirm original The tea acid fractions were combined and concentrated to 30 mg/mL to obtain a crude product of protocatechuic acid prepared in one dimension with a purity of 36.51% and a yield of 86.9%.

二维制备条件,色谱条件采用反相C18HC键合硅胶填料(制备柱规格:50×150mm,粒径10μm,孔径

Figure BDA0002813149430000061
质量300g,华谱新创科技有限公司),流动相选择(A)丙酮(有机相)-(B)含0.1%甲酸水(水相,质量浓度),采用体积浓度10%丙酮(流动相(A)等度洗脱(其余为流动相B),采用DAD紫外检测器选择320nm吸收波长,制备温度为25℃,进样量为20mL/针,流动相流速为60mL/min,按照检测器色谱峰曲线对原儿茶酸的馏分进行收集(按色谱峰收集),旋转蒸发至干,得到原儿茶酸化合物(产物经核磁和高分辨质谱结构解析,确定其为化合物原儿茶酸),经液相色谱分析,纯度为95.55%,收率93.2%。Two-dimensional preparation conditions, chromatographic conditions using reversed-phase C18HC bonded silica gel packing (preparative column specification: 50×150mm, particle size 10μm, pore size
Figure BDA0002813149430000061
Quality 300g, Huapu Xinchuang Science and Technology Co., Ltd.), mobile phase selection (A) acetone (organic phase)-(B) contains 0.1% formic acid water (water phase, mass concentration), adopts volume concentration 10% acetone (mobile phase ( A) Isocratic elution (the rest is mobile phase B), using a DAD ultraviolet detector to select 320nm absorption wavelength, the preparation temperature is 25°C, the injection volume is 20mL/needle, the mobile phase flow rate is 60mL/min, according to the detector chromatogram The fractions of protocatechuic acid were collected according to the peak curve (collected according to the chromatographic peak), and evaporated to dryness by rotary evaporation to obtain the protocatechuic acid compound (the product was determined to be the compound protocatechuic acid by NMR and high-resolution mass spectrometry structure analysis), After analysis by liquid chromatography, the purity was 95.55%, and the yield was 93.2%.

实施例2Example 2

称取桑黄药材100g,溶于2L水溶液,浸泡30小时后加热煮沸水提6小时,收集水提液,固体物料再次按加入2L水溶液重复加水煮沸提收集水提液,重复提取2次,合并得到水提液,得到桑黄药材水提溶液,浓度为1.2mg/mL,中空纤维膜膜过滤,中空纤维膜膜芯精度500000分子量,透过液浓缩至40mg/mL。Weigh Phellinus 100g, dissolve in 2L aqueous solution, soak for 30 hours, heat and boil for 6 hours, collect the water extract, add 2L of aqueous solution, add water and boil again, collect the water extract, repeat the extraction twice, combine The water extract was obtained, and the Phellinus medicinal material water extract solution was obtained, the concentration of which was 1.2 mg/mL, the hollow fiber membrane was filtered, the precision of the hollow fiber membrane core was 500000 molecular weight, and the permeate was concentrated to 40 mg/mL.

一维制备条件,色谱条件采用C8YE填料(制备柱规格:100×250mm,粒径60μm,孔径

Figure BDA0002813149430000073
质量1200g,华谱新创科技有限公司),流动相采用(A)乙腈(有机相)-(B)0.1%磷酸水(水相,v/v),台阶等度洗脱方式:纯水洗脱20min,乙腈(流动相A)体积浓度20%等度洗脱(其余为流动相B)60min,采用DAD紫外检测器选择254nm吸收波长,制备温度25℃,进样量为300mL/针,载样量0.75%(样品溶液固体质量与填料质量之比),流动相流速为300mL/min,按照检测器色谱峰曲线收集馏分,对所有馏分进行液相分析,确认原儿茶酸馏分,合并后浓缩至40mg/mL,得到一维制备原儿茶酸粗品,纯度46.82%,收率90.1%。One-dimensional preparation conditions, chromatographic conditions using C8YE packing (preparative column specifications: 100 × 250mm, particle size 60μm, pore size
Figure BDA0002813149430000073
Mass 1200g, Huapu Innovation Technology Co., Ltd.), the mobile phase is (A) acetonitrile (organic phase) - (B) 0.1% phosphoric acid water (water phase, v/v), step isocratic elution method: pure water washing Remove for 20min, acetonitrile (mobile phase A) volume concentration 20% isocratic elution (the rest is mobile phase B) for 60min, use DAD ultraviolet detector to select 254nm absorption wavelength, preparation temperature 25 ℃, injection volume is 300mL/needle, load Sample volume 0.75% (ratio of sample solution solid mass to filler mass), mobile phase flow rate is 300mL/min, collect fractions according to detector chromatographic peak curve, carry out liquid phase analysis to all fractions, confirm protocatechuic acid fraction, after merging Concentrate to 40 mg/mL to obtain the crude product of protocatechuic acid prepared in one dimension with a purity of 46.82% and a yield of 90.1%.

二维制备条件,色谱条件采用反相C18HC键合硅胶填料(制备柱规格:50×150mm,粒径10μm,孔径

Figure BDA0002813149430000074
质量300g,华谱新创科技有限公司),流动相选择(A)丙酮(有机相)-(B)0.5%磷酸水(水相,质量浓度),采用5%丙酮(流动相A)60min提高至25%丙酮(其余为流动相B)梯度洗脱,采用DAD紫外检测器选择320nm吸收波长,制备温度为18℃,进样量为25mL/针,流动相流速为60mL/min,按照检测器色谱峰曲线对原儿茶酸的馏分进行收集(按色谱峰收集),旋转蒸发至干,得到原儿茶酸化合物(产物经核磁和高分辨质谱结构解析,确定其为化合物原儿茶酸),经液相色谱分析,纯度为96.68%,收率93.8%。Two-dimensional preparation conditions, chromatographic conditions using reversed-phase C18HC bonded silica gel packing (preparative column specification: 50×150mm, particle size 10μm, pore size
Figure BDA0002813149430000074
Quality 300g, Hua Pu Xinchuang Science and Technology Co., Ltd.), mobile phase selection (A) acetone (organic phase)-(B) 0.5% phosphoric acid water (water phase, mass concentration), adopt 5% acetone (mobile phase A) 60min to improve Gradient elution to 25% acetone (the rest is mobile phase B), using a DAD ultraviolet detector to select 320nm absorption wavelength, the preparation temperature is 18°C, the injection volume is 25mL/needle, the mobile phase flow rate is 60mL/min, according to the detector The chromatographic peak curve collects the fractions of protocatechuic acid (collected according to the chromatographic peak), and rotary evaporates to dryness to obtain the protocatechuic acid compound (the product is determined to be the compound protocatechuic acid by NMR and high-resolution mass spectrometry structure analysis) , analyzed by liquid chromatography, the purity was 96.68%, and the yield was 93.8%.

对比例1Comparative example 1

与实施例1不同之处在于,以非基团修饰的硅胶(100~200目)为分离材料,其它条件同实施例1,无法富集得到原儿茶酸粗品,因此无法进行二维制备分离纯化,无法得到高纯原儿茶酸。The difference from Example 1 is that non-group-modified silica gel (100-200 mesh) is used as the separation material, and other conditions are the same as in Example 1, and the crude product of protocatechuic acid cannot be enriched, so two-dimensional preparation and separation cannot be carried out. Purification, high-purity protocatechuic acid cannot be obtained.

对比例2Comparative example 2

与实施例1不同之处在于,一维分离填料采用普通的十八烷基硅烷键合硅胶,其余制备条件相同,一维制备原儿茶酸粗品,液相分析纯度42.58%,收率44.9%。The difference from Example 1 is that ordinary octadecylsilane bonded silica gel is used as the one-dimensional separation filler, and the rest of the preparation conditions are the same. The crude product of protocatechuic acid is prepared one-dimensionally. The purity of liquid phase analysis is 42.58%, and the yield is 44.9%. .

二维分离填料采用普通的十八烷基硅烷键合硅胶,其余制备条件相同,经液相色谱分析,原儿茶酸纯度为79.48%,收率73.8%。Ordinary octadecylsilane bonded silica gel is used as the filler for two-dimensional separation, and the rest of the preparation conditions are the same. According to liquid chromatography analysis, the purity of protocatechuic acid is 79.48%, and the yield is 73.8%.

Claims (5)

1. A method for preparing protocatechuic acid from Phellinus linteus medicinal material comprises the following steps:
(1) Boiling and extracting Phellinus linteus medicinal material with pure water to obtain Phellinus linteus water extract;
(2) Filtering the Phellinus linteus water extract with hollow fiber membrane to obtain membrane permeate;
(3) Carrying out one-dimensional enrichment on membrane permeate liquid by using pure water-resistant C8YE silica gel filler to obtain crude protocatechuic acid, wherein the used chromatographic filler is C8YE filler, the elution condition is that acetonitrile is an organic phase, acid water is an aqueous phase, the aqueous phase is one or two of acetic acid and phosphoric acid, and the ratio is 0.01-3.0%, v/v; according to the isocratic of 1-30 percent of the organic phase, the linear gradient or the step gradient of 1-30 percent, the flow rate of 0.01-1.0 times of the filler volume/min, the temperature of 15-55 ℃ and the sample loading amount of 0.2-6.0 percent expressed by the ratio of the solid mass of the sample solution to the filler mass, the detector is a DAD ultraviolet detector, the elution time is 40-300 min, fractions are collected according to the chromatographic peak curve of the detector, liquid phase analysis is carried out on all the fractions, the protocatechuic acid fractions are confirmed, and the mixture is concentrated to 10-300 mg/mL to prepare a protocatechuic acid crude product in one dimension; (4) Preparing a protocatechuic acid crude product in two dimensions by using a polar copolymerization C18HC bonded silica gel filler to obtain a high-purity protocatechuic acid product, wherein the elution condition is that acetone is an organic phase, acid water is an aqueous phase and is a mobile phase, the aqueous phase is formic acid or phosphoric acid, and the ratio of the aqueous phase to the formic acid or phosphoric acid is 0.05-3.0%, and v/v; according to the isocratic of 1-50% of the organic phase, the linear gradient or the step gradient of 1-50%, the flow rate of 0.02-1.2 times of the filler volume/min, the temperature of 15-55 ℃, the sample loading amount expressed by the ratio of the solid mass of the sample solution to the filler mass of 0.1-4%, the detector is a DAD ultraviolet detector, the elution time is 15-200 min, the components of protocatechuic acid are collected according to the chromatographic peak curve of the detector, and the obtained fraction is dried in vacuum, so that the protocatechuic acid product with the purity of more than 95% can be obtained.
2. The method of claim 1, wherein the Phellinus linteus medicinal material is extracted by pure water at a feed liquid ratio of 1:20-1:150, m/v, and soaked for 2-72 hours; heating and boiling for extraction for 1-20 hours, collecting water extract, repeatedly adding water for boiling and extracting solid materials according to the feed-liquid ratio of 1:20-1:150 and m/v, collecting water extract, repeatedly extracting for 1-6 times, and combining to obtain the water extract.
3. The method of claim 1, wherein the water extract is subjected to hollow fiber membrane filtration by a membrane filtration technology, and the hollow fiber membrane filter core has a molecular weight of 5000-1000000, so as to obtain the hollow fiber membrane water phase permeate.
4. The method of claim 1, wherein pure water resistant C8YE silica gel filler is adopted for one-dimensional preparation, so that the method has a good enrichment effect on protocatechuic acid, the hollow fiber membrane aqueous phase permeate can be subjected to large-volume direct loading enrichment, the filler has a particle size of 5-200 mm, the pore diameter is 50-300 a, and crude protocatechuic acid is obtained through enrichment.
5. The method of claim 1, wherein the two-dimensional preparation adopts chromatographic packing as C18HC silica gel packing of polar copolymerization bonding technology, which can well retain protocatechuic acid, has good orthogonality with one-dimensional separation, and can separate and remove small molecular organic impurities, thereby obtaining high-purity protocatechuic acid, wherein the used chromatographic packing has a particle size of 5-200 mm and a pore diameter of 50-300A, and the protocatechuic acid product with a purity of >95% is prepared.
CN202011403414.0A 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material Active CN114573446B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011403414.0A CN114573446B (en) 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011403414.0A CN114573446B (en) 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material

Publications (2)

Publication Number Publication Date
CN114573446A CN114573446A (en) 2022-06-03
CN114573446B true CN114573446B (en) 2023-05-30

Family

ID=81768528

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011403414.0A Active CN114573446B (en) 2020-12-02 2020-12-02 Method for preparing protocatechuic acid from phellinus linteus medicinal material

Country Status (1)

Country Link
CN (1) CN114573446B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002371032A (en) * 2001-06-15 2002-12-26 Morikawa Kenkoudou Kk 3,5-diprenyl-4-hydroxycinnamic acid for standard sample and method for producing the same
WO2010036520A1 (en) * 2008-09-26 2010-04-01 Wisconsin Alumni Research Foundation Mesoporous metal oxide materials for phosphoproteomics
CN103120706A (en) * 2012-10-23 2013-05-29 北京华润高科天然药物有限公司 Method for preparing high-purity rutin via two-dimensional liquid chromatography-mass spectrometry combined technology
CN104098465A (en) * 2014-06-18 2014-10-15 广西万寿堂药业有限公司 Technological method for extraction of protocatechuic acid from Blumea riparia (Bl.) DC
WO2016161138A1 (en) * 2015-03-31 2016-10-06 Stamets Paul Edward Antiviral activity from medicinal mushrooms and their active constituents
CN109908188A (en) * 2019-04-15 2019-06-21 吉林省蒲川生物医药有限公司 A kind of Phellinus anti-cancer effective component extract and its preparation method and purposes
CN111329905A (en) * 2018-12-18 2020-06-26 泰州医药城国科化物生物医药科技有限公司 Total alkaloid component extracted from coptis chinensis and refining method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002371032A (en) * 2001-06-15 2002-12-26 Morikawa Kenkoudou Kk 3,5-diprenyl-4-hydroxycinnamic acid for standard sample and method for producing the same
WO2010036520A1 (en) * 2008-09-26 2010-04-01 Wisconsin Alumni Research Foundation Mesoporous metal oxide materials for phosphoproteomics
CN103120706A (en) * 2012-10-23 2013-05-29 北京华润高科天然药物有限公司 Method for preparing high-purity rutin via two-dimensional liquid chromatography-mass spectrometry combined technology
CN104098465A (en) * 2014-06-18 2014-10-15 广西万寿堂药业有限公司 Technological method for extraction of protocatechuic acid from Blumea riparia (Bl.) DC
WO2016161138A1 (en) * 2015-03-31 2016-10-06 Stamets Paul Edward Antiviral activity from medicinal mushrooms and their active constituents
CN111329905A (en) * 2018-12-18 2020-06-26 泰州医药城国科化物生物医药科技有限公司 Total alkaloid component extracted from coptis chinensis and refining method thereof
CN109908188A (en) * 2019-04-15 2019-06-21 吉林省蒲川生物医药有限公司 A kind of Phellinus anti-cancer effective component extract and its preparation method and purposes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
9种桑黄子实体中两种酚类活性成分的HPLC含量测定;秦春华等;《湖北中医药大学学报》;20150620;第17卷(第03期);第36-39页 *

Also Published As

Publication number Publication date
CN114573446A (en) 2022-06-03

Similar Documents

Publication Publication Date Title
US20220348603A1 (en) Isomerization feature-based method for purifying punicalagin
CN100567249C (en) The preparation method of danshen root salvianolic acid A
CN105294623A (en) Sesquiterpene lactone compound, preparation method and application thereof
CN101050241A (en) Method for preparing MDG-1 polysaccharide of lilyturf root
CN102078339A (en) Method for enriching and purifying common phellinus fungus general flavone in common phellinus fungus
CN101289429A (en) A kind of separation and preparation method of Yichun
CN114573446B (en) Method for preparing protocatechuic acid from phellinus linteus medicinal material
CN102526150A (en) Method for preparing total elecampane sesquiterpene lactone extract
CN102070683B (en) Method for simultaneously preparing chemical reference substances of parishin, parishin B and parishin C
CN101234147A (en) Preparation method of total flavonoids from Trollus chinensis for injection
CN101210041A (en) A kind of separation and preparation method of tanshinone Ⅱ A chemical reference substance
CN1268631C (en) Technique for preparing general flavone of Chinese globeflower with short petal some medicinal substances in high purity
CN115304651B (en) Method for extracting acteoside from paulownia leaves
CN104892550B (en) A kind of method that 10 deacetylate baccatin IIIs of separation (10 DAB III) are extracted from Chinese yew
CN110240585B (en) Preparation method of agilawood tetraol
CN102389456A (en) Method for extracting isodon japonica var.galaucocalyx total diterpenoids or Glaucocalyxin A
CN112851621A (en) Total iridoid extract of caulis et folium piperis, extraction and purification method and application thereof
CN102432419A (en) Method for extracting and separating beta-elemene from Eupatorium adenophorum
CN102391328B (en) Method for simultaneously preparing chemical reference substances magnoloside A and magnoloside B
CN108191933B (en) A kind of method for preparing new astilbin using tuckahoe as raw material
CN102078400B (en) Preparation method of extract of total triterpene acid of loquat leaf
CN114573539B (en) A method for preparing compound Phellibaumin D from Phellinus igniarius medicinal material
CN111551656A (en) A kind of preparation method of high-purity Corylargin
CN101130498B (en) Method for extracting and purifying salvianolic acid A
CN111388542A (en) Method for extracting monoterpene glycoside active ingredient from non-medicinal part of radix paeoniae alba

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant